patent/KR-20110068191-A

http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-20110068191-A

Outgoing Links

Predicate	Object
assignee	http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_259045c6eba6e2c5d338b84e0a88b571
classificationCPCAdditional	http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2236-33
classificationCPCInventive	http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-192 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-37 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-122 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-216 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23L29-035 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-12
classificationIPCInventive	http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A23L1-30 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-65 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K36-37 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-12
filingDate	2009-12-15-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor	http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6d4413868808d9b1906b1ca694527976 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_cd588ea17c0083a1af355317f15bab92 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5469956bd32d383c64dfd8add3da2289 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8b3f6883dc7da0c28c973ea2bde60ede http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f68b58ddd6aee85ccc6e824cfc6408d4 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7d4a35fabcb89fcbec38b2d273b2ceb7 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_94c9c5eade10edb24180e77f78538806 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_44337c9f7d3ef4a274111e55f3d77950
publicationDate	2011-06-22-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber	KR-20110068191-A
titleOfInvention	Composition for preventing or treating coronavirus infection and composition for inhibiting 3CL protease activity
abstract	The present invention relates to a composition for the prevention or treatment of coronavirus infection and the composition for the inhibition of 3CL protease activity, including the buckthorn extract or Wakame tree extract, buckwheat extract or fractions thereof, Wakame tree extract or fractions thereof In addition, the quinomethed triterpene compounds extracted from these compounds exhibit the effect of inhibiting the activity of the 3CL protease and simultaneously show the effect of inhibiting virucidal and cytopathic activity against various coronaviruses, and thus can be useful for the prevention or treatment of coronavirus infection. Can be.
isCitedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-103156902-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-20190082581-A
priorityDate	2009-12-15-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type	http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate	Subject
isDiscussedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID467390086

Total number of triples: 31.